Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis

Respirology

Volumn 18, Issue 8, 2013, Pages 1230-1235

  Ruchaud Sparagano, Marie Hélène ^a   Gertig, Helen ^a   Hester, Katy L M ^b   Macfarlane, James G ^a   Corris, Paul A ^a   Simpson, A John ^a   De Soyza, Anthony ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

bronchiectasis; granulocyte macrophage colony stimulating factor; neutrophil; phagocytosis; superoxide

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SUPEROXIDE; ZYMOSAN;

ADULT; AGED; ARTICLE; BRONCHIECTASIS; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; MALE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

BRONCHIECTASIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; NEUTROPHIL; PHAGOCYTOSIS; SUPEROXIDE;

AGED; BRONCHIECTASIS; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PHAGOCYTOSIS; PLATELET ACTIVATING FACTOR; SUPEROXIDES; ZYMOSAN;

EID: 84886856089     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12138     Document Type: Article

References (33)

1. Barker AF,. Bronchiectasis. N. Engl. J. Med. 2002; 346: 1383-1393.
2. Seitz AE, Olivier KN, Adjemian J, et al. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000-2007. Chest 2012; 142: 432-439.
3. Gaga M, Bentley AM, Humbert M, et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998; 53: 685-691.
4. Fuschillo S, De Felice A, Balzano G,. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur. Respir. J. 2008; 31: 396-406.
5. Cowburn AS, Condliffe AM, Farahi N, et al. Advances in neutrophil biology: clinical implications. Chest 2008; 134: 606-612.
6. Amulic B, Cazalet C, Hayes GL, et al. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 2012; 30: 459-489.
7. Hill AT, Campbell EJ, Hill SL, et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am. J. Med. 2000; 109: 288-295.
8. Zheng L, Tipoe G, Lam WK, et al. Up-regulation of circulating adhesion molecules in bronchiectasis. Eur. Respir. J. 2000; 16: 691-696.
9. Martínez-García MA, Soler-Cataluña JJ, Perpiñá-Tordera M, et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007; 132: 1565-1572.
10. Simpson JL, Grissell TV, Douwes J, et al. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2007; 62: 211-218.
11. Courtney JM, Kelly MG, Watt A, et al. Quality of life and inflammation in exacerbations of bronchiectasis. Chron. Respir. Dis. 2008; 5: 161-168.
12. Hernando R, Drobnic ME, Cruz MJ, et al. Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis. Int. J. Clin. Pharm. 2012; 34: 644-650.
13. Whitters D, Stockley R,. Immunity and bacterial colonisation in bronchiectasis. Thorax 2012; 67: 1006-1013.
14. Hester KL, Macfarlane JG, Tedd H, et al. Fatigue in bronchiectasis. QJM 2012; 105: 235-240.
15. Conway Morris A, Kefala K, Wilkinson TS, et al. C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am. J. Respir. Crit. Care Med. 2009; 180: 19-28.
16. Conway Morris A, Brittan M, Wilkinson TS, et al. C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood 2011; 117: 5178-5188.
17. Pasteur MC, Bilton D, Hill AT,. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65 (Suppl. 1): i1-58.
18. Anonymous. Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Respir. Med. 1994; 88: 165-194.
19. Dransfield I, Buckle AM, Savill JS, et al. Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J. Immunol. 1994; 153: 1254-1263.
20. Koller DY, Urbanek R, Götz M,. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am. J. Respir. Crit. Care Med. 1995; 152: 629-633.
21. Brockbank S, Downey D, Elborn JS, et al. Effect of cystic fibrosis exacerbations on neutrophil function. Int. Immunopharmacol. 2005; 5: 601-608.
22. King PT, Hutchinson P, Holmes PW, et al. Assessing immune function in adult bronchiectasis. Clin. Exp. Immunol. 2006; 144: 440-446.
23. Voglis S, Quinn K, Tullis E, et al. Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs. Am. J. Respir. Crit. Care Med. 2009; 180: 159-166.
24. Shirai T, Sato A, Chida K,. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity. Intern. Med. 1995; 34: 469-474.
25. Ruparelia P, Szczepura KR, Summers C, et al. Quantification of neutrophil migration into the lungs of patients with chronic obstructive pulmonary disease. Eur. J. Nucl. Med. Mol. Imaging 2011; 38: 911-919.
26. 111- labelled granulocyte accumulation in respiratory tract of patients with bronchiectasis. Lancet 1987; 1: 1335-1339.
27. Mikami M, Llewellyn-Jones CG, Bayley D, et al. The chemotactic activity of sputum from patients with bronchiectasis. Am. J. Respir. Crit. Care Med. 1998; 157: 723-728.
28. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am. J. Respir. Crit. Care Med. 2000; 162: 1277-1284.
29. King P, Bennett-Wood V, Hutchinson P, et al. Bactericidal activity of neutrophils with reduced oxidative burst from adults with bronchiectasis. APMIS 2009; 117: 133-139.
30. Llewellyn-Jones CG, Johnson MM, Mitchell JL, et al. In vivo study of indomethacin in bronchiectasis: effect on neutrophil function and lung secretion. Eur. Respir. J. 1995; 8: 1479-1487.
31. Culic O, Erakovic V, Cepelak I, et al. Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur. J. Pharmacol. 2002; 450: 277-289.
32. Llewellyn-Jones CG, Hill SL, Stockley R,. Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro. Thorax 1994; 49: 207-212.
33. Busse PJ, Mathur SK,. Age-related changes in immune function: effect on airway inflammation. J. Allergy Clin. Immunol. 2010; 126: 690-699.